
NFL BIOSCIENCES: STRENGTHENING OF A FOUNDING SHAREHOLDER BY EXERCISE OF BSPCE – 07/05/2023 at 19:01
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company that develops botanical drugs for the treatment of addictions and dependencies, has been informed of the exercise of 50,000 business creator warrants (“BSPCE ”) held by Mr. Bruno Lafont, Deputy CEO and co-founder of NFL Biosciences, giving him the right to subscribe to…